Viz.ai has announced a number of new features at the Society of Vascular and Interventional Neurology (SVIN) annual meeting in Atlanta, USA (20–23 November, 2019). The latest software, available as a free software update to Viz.ai customers, features customisable alerts based on CT perfusion, proprietary mobile 3D reconstruction, multi-planar reconstruction (MPR), maximum intensity Projection (MIP) reconstruction, and built-in HIPAA compliant direct and group messaging. In addition, Viz.ai has added an ability to notify and share cases between specialists with a click of a button; this all-in-one mobile application allows stroke teams to synchronise care seamlessly.
Viz.ai, the only company with US Food and Drug Administration (FDA) clearance for large vessel occlusion (LVO detection), have added the ability for clinicians to set a desired tMax threshold, which can notify them about hypoperfusion in any part of the vasculature and allows specialists to define the alerts they want to receive.
“Stroke is the second leading cause of death worldwide. Our goal at Viz.ai is to decrease the time to treatment and increase the number of patients receiving life-saving treatment,” said Chris Mansi, CEO and Co-Founder of Viz.ai.
A press release states, “Unlike other stroke software in the space, Viz.ai is built with a security-first mentality and proven emphasis on protecting patient and facility information. Viz.ai is the first and only AI stroke company to achieve organisational compliance (SOC 2 Type 2) with federal laws restricting health information (HIPPA Attestation certification), in addition to 6 ISO certifications.” Viz.ai’s acute ischemic stroke software is now available in over 300 hospitals across the USA.
